Managing oncology drug costs in a constrained environment

Your saved search

Your RSS Feed

. 2019 Feb;17(2):90-93.

Affiliations

Peter Clark. Clin Adv Hematol Oncol. 2019 Feb.

. 2019 Feb;17(2):90-93.

No abstract available

Similar articles

ASCO Rx for high drug costs: doctors and patients need to talk.
Nicholas J. Nicholas J. J Natl Cancer Inst. 2009 Nov 4;101(21):1441-4. doi: 10.1093/jnci/djp398. Epub 2009 Oct 14. J Natl Cancer Inst. 2009. PMID: 19828870 No abstract available.
Value in Oncology: It Is in the Eyes of the Beholder.
Nabhan C, Phillips EG, Feinberg BA. Nabhan C, et al. J Natl Compr Canc Netw. 2019 Jan;17(1):2-5. doi: 10.6004/jnccn.2018.7092. J Natl Compr Canc Netw. 2019. PMID: 30659123 No abstract available.
Seeking value as cancer drug costs soar.
Bender E. Bender E. Cancer Discov. 2013 Aug;3(8):833-4. doi: 10.1158/2159-8290.CD-ND2013-018. Epub 2013 Aug 1. Cancer Discov. 2013. PMID: 23928760
Key factors impacting the delivery and financing of oncology care in the United States.
Goldsmith PJ, Paivanas T. Goldsmith PJ, et al. J Natl Compr Canc Netw. 2006 May;4(5):434-7. doi: 10.6004/jnccn.2006.0036. J Natl Compr Canc Netw. 2006. PMID: 16715607 Review. No abstract available.
American Society of Clinical Oncology Position Statement on Addressing the Affordability of Cancer Drugs.
American Society of Clinical Oncology. American Society of Clinical Oncology. J Oncol Pract. 2018 Mar;14(3):187-192. doi: 10.1200/JOP.2017.027359. Epub 2017 Nov 1. J Oncol Pract. 2018. PMID: 29091534 Review. No abstract available.